AXGN compared with TNDM: revenue, margins and what each company keeps, and the suppliers and customers both name

AXGNAxogen, Inc.

Mkt capRevenueRevenue

TNDMTandem Diabetes Care Inc

Mkt capRevenueRevenue

Compare

AXGNAxogen, Inc.

TNDMTandem Diabetes Care Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AXGN

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±19.5%▲+31.47%×1.62

Q2 FY26±16.1%▲+0.53%×0.03

Q1 FY26±15.4%▲+6.60%×0.43

Feb 24 '26±13.3%▼−8.14%×0.61

TNDM

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±17.0%▲+19.11%×1.12

Q1 FY26±19.9%▼−16.19%×0.81

= impliedAXGN realized, solidTNDM realized, hatchedOne scale, both sides: full bar = 33%× = |realized| ÷ impliedSource: market data

Feb 20 '26

±13.6%

▲+32.67%

×2.40

Q3 FY25±22.0%▲+21.98%×1.00

AXGNAxogen, Inc.

49.57▼−0.56%

Mkt cap$2.9BRevenue$76MQ3 FY26Revenue$225MFY25

TNDMTandem Diabetes Care Inc

17.86▼−4.34%

Regular sessionNov 3 '26

Mkt cap$1.3BRevenue$255MQ2 FY26Revenue$1.0BFY25

Compare

Regular sessionNov 3 '26

AXGNAxogen, Inc.

TNDMTandem Diabetes Care Inc

49.57▼−0.56%

Price

17.86▼−4.34%

$2.9B

Mkt cap

$1.3B

Q3 FY26$76M

Revenue

$255MQ2 FY26

FY25$225M

Revenue

$1.0BFY25

AXGN49.57▼−0.56%vsTNDM17.86▼−4.34%Regular sessionNov 3 '26